Evidence map›Paper›PMID 40083354›Full record

ReviewJournal of public health in Africa2025

Post-exposure testing at healthcare facilities with SARS-CoV-2 transmission: A rapid review.

Emmanuel E Effa, Okokon Ita, Joshua Mwankon, Funmi Siyanbade, Francis Iwomi, Eleanor Ochodo, Gemma Villanueva, Martin M Meremikwu

Abstract readReview
In one paragraph

Review in Journal of public health in Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emmanuel E EffaDepartment of Internal Medicine, Faculty of Clinical Sciences, University of Calabar, Calabar, Nigeria.ORCID https://orcid.org/0000-0002-5654-2963
Okokon ItaDepartment of Medical Microbiology, Faculty of Laboratory Medicine, University of Calabar, Calabar, Nigeria.ORCID https://orcid.org/0000-0003-1149-3130
Joshua MwankonDepartment of Family Medicine, Faculty of Clinical Sciences, University of Calabar, Calabar, Nigeria.ORCID https://orcid.org/0000-0002-1703-6670
Funmi SiyanbadeSchool of Nursing, University of Calabar Teaching Hospital, Calabar, Nigeria.ORCID https://orcid.org/0009-0003-3277-7834
Francis IwomiCochrane Nigeria, Calabar Institute of Tropical Disease Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.ORCID https://orcid.org/0009-0005-3154-5956
Eleanor OchodoCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.ORCID https://orcid.org/0000-0002-7951-3030
Gemma VillanuevaCochrane Response, Cochrane, London, United Kingdom.ORCID https://orcid.org/0000-0002-1306-1721
Martin M MeremikwuDepartment of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria.ORCID https://orcid.org/0000-0002-6144-9413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-exposure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing following health facility outbreaks may control the spread of infection. Aim: This study aimed to assess the impact of testing for SARS-CoV-2 infection on health outcomes during healthcare facility outbreaks. Setting: This review included studies conducted at skilled nursing facilities, a cancer centre, and a geriatric psychiatric facility. Methods: We followed the methods for conducting rapid systematic reviews, searched databases from December 2019 to August 2022, assessed the risk of bias using the modified Newcastle Ottawa scale, and graded the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. We pooled the prevalence, mortality, and hospitalisation results as appropriate. Results: Of the 3055 articles from database search, no study was eligible for inclusion as outlined in the protocol. However, eight non-comparative reports (case series) in skilled nursing facilities were included. The pooled prevalence of SARS-CoV-2 infection among residents of care homes and patients were 38% (95% confidence interval [CI] = 25% - 51%; 5 studies, 2044 participants; Conclusion: There is no identified evidence for or against testing of people in healthcare facilities where there is ongoing transmission of SARS-CoV-2 infection. Contribution: The evaluation of the effectiveness of testing strategies during SARS-CoV-2 outbreaks need baseline and follow-up data from well-designed before and after studies appropriate for the setting.

Indexed as

healthcare facilitiespost-exposure testingSARS-CoV-2systematic reviewtransmission

Identifiers

PMID40083354
PMCPMC11905177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.